EthereumHalozyme Therapeutics xStock is a backed xstock tracking Halozyme Therapeutics. It is an ERC-20 on Ethereum, so it can be held in any wallet the issuer permits and composed into on-chain applications. Prism verified the contract directly on-chain: it reports the symbol its issuer publishes and a readable supply.
Tokenized exposure to Halozyme Therapeutics, settled on-chain.
Prism analyst note
Halozyme Therapeutics xStock gives economic exposure to Halozyme Therapeutics without holding the security itself. The contract was verified on-chain by Prism. Reference price is the underlying's last close (HALO); the token can trade away from it, and Prism quotes every trade live before you sign.
Generated from issuer disclosures and reviewed against the sources listed below. Not investment advice.
Related assets
See more
Prism read this token's contract directly on its chain and confirmed the figures the issuer publishes.
- What was checked
- Prism read this token's contract on Ethereum and confirmed the symbol, decimals, and supply the issuer publishes.
- Last verified
- Sep 26, 2026
- Token contract
- 0xCde0…297D
- Custody
- Regulated third-party custodian
Documents & disclosures
Frequently asked
Do I own the underlying security?+
No. This is a tokenized instrument giving economic exposure. Rights are defined by the issuer's own terms, not by share ownership.
How was this verified?+
Prism called the contract directly on its chain and confirmed it reports the symbol and decimals its issuer publishes, with a readable non-zero supply. The full record is on the verification page.
Can I trade it right now?+
Prism quotes every trade live at the moment you ask. If no route exists at your size you will see that before signing rather than after.